Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-9050118

  • Global Nuclear Medicine Equipment Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • Publish: January 2018 | Report Code: HME-9050118

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Nuclear medicine equipment uses special imaging devices such as gamma camera and single photon emission computed tomography that detects radioactive energy which is emitted from patient body and transform it into an image. It uses radioactive substance which is inserted into the body and gives prescribed information about the disease of the patients. This is the best method mostly used by doctors to determine and diagnosis disease of the patients. The global nuclear medicine equipment market is expected to rise with a CAGR of 3.5% during the forecast period 2016-2023. Some of the nuclear medicine equipment used are scintillation camera and other medical imaging equipment. Nuclear systems capture the radiations emitted by radiopharmaceuticals to produce images of the structures and activities inside the human body. These images help the physicians to examine the human body to determine the cause of an injury or illness or injury and provide an accurate diagnosis.

The key factor driving the market growth is the advances in radiotracers. In 2016, molecular imaging had been defined by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) as the characterization, visualization and measurement of biological processes at the cellular and molecular levels in humans and other living beings. According to National Center for Biotechnology Information (U.S.), there is a surging demand for development of novel radiopharmaceuticals for new molecular targets. Moreover, there are highly effective precursor molecules, radionuclides and radiopharmaceuticals. These include fluorine-18-fluoro-L-dihydroxyphenylalanine (FDOPA), fluorine-18-fluorocholine, fluorine-18-fallypride, iodine-123-meta-iodobenzylguanidine (MIBG), fluorine-18-fluoroprophyl-β-carbomethyoxy-3β-(4-iodophenyltropane) (FP-CIT), etc. They are not readily available to institutions due to absence of infrastructure for isotope production or radiopharmaceutical chemistry. Therefore, there is surging demand for large availability of specialized radiopharmaceuticals both for clinical treatment and diagnosis and also as research tools in the exploration of novel applications. For instance, MIBG was previously used majorly for detection and treatment of neuroendocrine tumors, however, it has proved to be effective in the early diagnosis of heart failure.

Source: OBRC Analysis.

The report on global nuclear medicine equipment market includes product, application and end user.

Product segment of nuclear medicine equipment include:

·         Single Photon-Emission Computed Tomography (SPECT)

·         Hybrid PET (Positron emission tomography)

·         Planar Scintigraphy

The applications segment of nuclear medicine equipment includes:

·         Cardiology

·         Oncology

·         Neurology

·         Others

The end users segment of nuclear medicine equipment includes:

·         Hospitals

·         Imaging Centers

·         Academic and Research Centers

·         Others

The report scope is widely categorized on the basis of products of nuclear medicine equipment which include SPECT, Hybrid PET and Planar Scintigraphy.

 

The global nuclear medicine equipment market report has been geographically segmented in:

·         North America (U.S. & Canada)

·         Asia Pacific (China, India, Japan, RoAPAC)

·         Europe (UK, France, Germany, RoE)

·         Rest of World

Geographically, North America is the dominating region for global nuclear medicine equipment market. The key factor responsible for the market growth in North America is the increased adoption and growth of nuclear medicine in U.S. due to various technological advancements in nuclear medicine equipment. Moreover, the emergence of new radiopharmaceuticals for therapeutics and diagnostics, highly developed healthcare infrastructure etc. are some of the additional factors responsible for the North America market growth. However, Asia Pacific is expected to emerge as the fastest growing market during the forecast period 2016-2023. This is due to the increased research and development in the field of nuclear medicine in developing countries such as China, Japan, India, Australia, etc. Moreover, the growing healthcare expenditure, rising geriatric population, increasing prevalence of cardiovascular and neurological diseases such as cancer, cardiovascular diseases, Alzheimer’s, Parkinson’s, etc. has led to surging demand for nuclear medicine equipment. Also, the increasing nuclear medicine practice in Japan is highly developed accompanied by a significant increase in the number of hybrid SPECT/CT examinations.

Global nuclear medicine equipment market report covers segmentation analysis of product, applications and end users. Report further covers segments of product segment of nuclear medicine equipment market which include Single Photon-Emission Computed Tomography (SPECT), Hybrid PET (Positron emission tomography) and Planar Scintigraphy. The SPECT product segment is further segmented into standalone SPECT and hybrid SPECT. SPECT is the leading product segment due to its low cost, high usage and better availability as compared to PET. Report further covers segments of applications of nuclear medicine equipment which includes cardiology, oncology, neurology and others. Cardiology is the leading application segment. Nuclear medicine is adopted in cardiology for the treatment of cardiomyopathy and Coronary Heart Disease (CHD). CHD is a chronic disease and major proportion of the public is affected by CHD thereby leading to death and physical disability in the population of developing nations. However, oncology is the fastest growing application segment owing to the increasing prevalence of cancer. According to American Cancer Society, approximately 13% of the deaths globally are due to cancer. Moreover, the increasing health awareness among the people have led to conduction of  regular check-ups to detect the symptoms associated with the disease, thereby resulting in a surging demand for nuclear medicine equipment. Furthermore, screening methods for oncology using nuclear medicine equipment are expected to positively influence the market growth. The end users of nuclear medicine equipment include hospitals, imaging centers, academic and research centers and others.

The major market players of the global nuclear medicine equipment market are:

·         CMR Naviscan Corporation

·         GE Healthcare

·         Hitachi Medical Corporation

·         Medtronic Inc.

·         Siemens AG

·         Others

These companies are using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger and acquisition is the key strategy adopted by the companies in the nuclear medicine equipment market.

For Example; In March 2017, Hitachi Medical Corporation had signed joint venture agreement with Redlen Technologies Inc. in order to develop an X-ray detector module, a direct conversion semiconductor to be used in new photon counting computed tomography systems (PCCT). This strategic initiative was taken as a step to enhance the company’s product portfolio.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in nuclear medicine equipment market.

Key reason to buy the report:

·         The report includes market estimation, forecast and analysis for the forecast period 2016-2023

·         Report includes detailed analysis of different segments such as product, application and end user of the global nuclear medicine equipment market.

·         Identify and understand the strengths, opportunities, challenges and threats of the nuclear medicine equipment market.

·         Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of the global nuclear medicine equipment market.

·         Detailed analysis of various the regulatory policies which are affecting the global nuclear medicine equipment market.

How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share and market segmentations. Our report on global nuclear medicine equipment market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the nuclear medicine equipment market with extensive SCOT analysis of key companies. 

Key findings of the global nuclear medicine equipment market:

·         North America is the dominating region for the global nuclear medicine equipment market.

·         SPECT is the leading product segment due to its low cost, high usage and better availability as compared to PET.

·         Merger and acquisition is the key strategy adopted by the companies in the global nuclear medicine equipment market. 

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATOR FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INTRODUCTION OF NEW AND ADVANCED PRODUCTS
3.1.2. PUBLIC-PRIVATE PARTNERSHIP INVESTMENTS 
3.1.3. ADVANCES IN RADIOTRACERS
3.1.4. INCREASING PREVALENCE OF CANCER AND CARDIAC AILMENTS
3.1.5. INCREASING GERIATRIC POPULATION
3.2. MARKET RESTRAINTS
3.2.1. SHORTER HALF-LIFE OF RADIOPHARMACEUTICALS
3.2.2. HIGH COST OF NUCLEAR MEDICINE EQUIPMENT
3.3. MARKET OPPORTUNITIES
3.3.1. STRONG PRODUCT PIPELINE
3.3.2. HIGH DEMAND IN EMERGING MARKETS
3.4.   MARKET CHALLENGES 
3.4.1. INCREASING ADOPTION OF REFURBISHED DIAGNOSTIC IMAGING SYSTEMS
3.4.2. HOSPITAL BUDGET CUTS
 
4. MARKET SEGMENTATION 
4.1. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY PRODUCT 
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL HYBRID PET SYSTEMS MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL PLANAR SCINTIGRAPHY MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY APPLICATION 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL CARDIOLOGY MARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL ONCOLOGY MARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL NEUROLOGY MARKET 
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.4. GLOBAL OTHER APPLICATIONS MARKET 
4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.5.4.3. TOP PLAYERS & KEY PRODUCTS 
4.2.5.4.4. KEY CONCLUSIONS
4.3. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY END USER 
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL HOSPITALS MARKET 
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL IMAGING CENTERS MARKET 
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL ACADEMIC AND RESEARCH CENTERS MARKET 
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL OTHER END USERS MARKET 
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.4.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. CMR NAVISCAN CORPORATION (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS 
7.1.5. STRATEGIC ANALYSIS
7.2. DDD-DIAGNOSTIC A/S (DENMARK)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.2.5. STRATEGIC ANALYSIS
7.3. DIGIRAD CORPORATION (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. FUJIFILM HOLDINGS (JAPAN)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. GE HEALTHCARE (UK)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS 
7.5.5. STRATEGIC ANALYSIS
7.6. HITACHI MEDICAL CORPORATION (JAPAN)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. HOLOGIC (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. MEDISO MEDICAL IMAGING SYSTEMS LTD (HUNGARY)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. MEDTRONIC INC. (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. NEUSOFT MEDICAL SYSTEMS CO. LTD. (CHINA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS 
7.10.5. STRATEGIC ANALYSIS
7.11. PHILIPS HEALTHCARE (NETHERLANDS)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. SHIMADZU CORPORATION (JAPAN)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. SIEMENS AG (GERMANY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. SURGICEYE GMBH (GERMANY)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. TOSHIBA MEDICAL SYSTEMS CORPORATION (JAPAN)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS 
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY PRODUCT 2014-2023 ($ MILLION)
2. GLOBAL SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT) MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL HYBRID PET MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL PLANAR SCINTIGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY APPLICATION 2014-2023 ($ MILLION)
6. GLOBAL CARDIOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL ONCOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL NEUROLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET BY  END USER 2014-2023 ($ MILLION)
11. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL IMAGING CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL ACADEMIC AND RESEARCH CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL OTHER END USER MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. NORTH AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
16. EUROPE NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
17. ASIA PACIFIC NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
18. REST OF THE WORLD NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION) 
 
LIST OF FIGURES
1. GLOBAL SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)  MARKET 2014-2023 ($ MILLION)
2. GLOBAL HYBRID PET MARKET 2014-2023 ($ MILLION)
3. GLOBAL PLANAR SCINTIGRAPHY MARKET 2014-2023 ($ MILLION)
4. GLOBAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
5. GLOBAL ONCOLOGY MARKET 2014-2023 ($ MILLION)
6. GLOBAL NEUROLOGY MARKET 2014-2023 ($ MILLION)
7. GLOBAL OTHER APPLICATIONS MARKET 2014-2023 ($ MILLION)
8. GLOBAL HOSPITALS MARKET 2014-2023 ($ MILLION)
9. GLOBAL IMAGING CENTERS MARKET 2014-2023 ($ MILLION)
10. GLOBAL ACADEMIC AND RESEARCH CENTERS MARKET 2014-2023 ($ MILLION)
11. GLOBAL OTHER END USER MARKET 2014-2023 ($ MILLION)
12. UNITED STATES (U.S.) NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
13. CANADA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
14. UNITED KINGDOM (UK) NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
15. FRANCE NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
16. GERMANY NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
17. SPAIN NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
18. ROE NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
19. INDIA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
20. CHINA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
21. JAPAN NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
22. AUSTRALIA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
23. ROAPAC NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
24. LATIN AMERICA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)
25. MENA NUCLEAR MEDICINE EQUIPMENT MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion